Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An In Vivo 24-Hour Recovery Study of Leukoreduced RBCs After Automated Separation of Whole Blood by the Reveos System and Storage for 42 Days

NCT05239455 is registered in ClinicalTrials.gov with Terumo BCT as lead sponsor.

NCT NCT05239455
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05239455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An In Vivo 24-Hour Recovery Study of Leukoreduced RBCs After Automated Separation of Whole Blood by the Reveos System and Storage for 42 Days
Lead sponsor
Terumo BCT
Phase
Not applicable
Overall status
Completed
Start date
November 11, 2021
Completion date
April 30, 2022
Enrollment
37 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

device validation of in-vivo performance